November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Aref Al-Kali: AML is hanging with use of FLT3i and Allo BMT
Jul 8, 2024, 16:34

Aref Al-Kali: AML is hanging with use of FLT3i and Allo BMT

Aref Al-Kali, Hematologist/Oncologist at Mayo Clinic, shared on X:

Outcome of t6;9 AML changing with use of FLT3i and Allo BMT. Plan for larger multisite study lead by Clifford Csizmar.

FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214).”

Source: Aref Al-Kali/X

FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): The Mayo Clinic experience

Authors: Clifford M CsizmarAntoine N SalibaPatricia T GreippHassan AlkhateebKebede H BegnaJames M ForanNaseema GangatWilliam J HoganC Christopher HookMark R LitzowAbhishek A MangaonkarJeanne M PalmerAnimesh PardananiMithun V ShahAyalew TefferiMehrdad Hefazi TorghabehAlexandra P Wolanskyj-SpinnerMrinal M PatnaikScott H KaufmannAref Al-Kali